Risk of gonadotoxicity with immunotherapy and targeted agents remains an unsolved but crucial issue

Eur J Clin Invest. 2022 Jul;52(7):e13779. doi: 10.1111/eci.13779. Epub 2022 Apr 2.

¹ Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.
² Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
³ Division of Breast Surgery, Ospedale Villa Scassi, Genova, Italy.
⁴ Fertility clinic, CUB-Erasme Hospital, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
⁵ MRC Centre for Reproductive Health, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.

No abstract available

Keywords: breast cancer; immunotherapy; oncofertility; targeted agents.

Publication types